alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2010296EN.01001201.xml

| 30.10.2010 | EN | Official Journal of the European Union | C 296/12 |
| --- | --- | --- | --- |

30.10.2010

EN

Official Journal of the European Union

C 296/12

---

Euro exchange rates (1)

1

29 October 2010

2010/C 296/06

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,3857 |
| JPY | Japanese yen | 111,87 |
| DKK | Danish krone | 7,4562 |
| GBP | Pound sterling | 0,86860 |
| SEK | Swedish krona | 9,3610 |
| CHF | Swiss franc | 1,3708 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 8,1920 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,598 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 271,76 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7097 |
| PLN | Polish zloty | 3,9820 |
| RON | Romanian leu | 4,2663 |
| TRY | Turkish lira | 1,9887 |
| AUD | Australian dollar | 1,4216 |
| CAD | Canadian dollar | 1,4150 |
| HKD | Hong Kong dollar | 10,7467 |
| NZD | New Zealand dollar | 1,8280 |
| SGD | Singapore dollar | 1,7968 |
| KRW | South Korean won | 1 557,90 |
| ZAR | South African rand | 9,6827 |
| CNY | Chinese yuan renminbi | 9,2437 |
| HRK | Croatian kuna | 7,3470 |
| IDR | Indonesian rupiah | 12 383,89 |
| MYR | Malaysian ringgit | 4,3090 |
| PHP | Philippine peso | 59,741 |
| RUB | Russian rouble | 42,7523 |
| THB | Thai baht | 41,509 |
| BRL | Brazilian real | 2,3638 |
| MXN | Mexican peso | 17,1544 |
| INR | Indian rupee | 61,5200 |

Currency

Exchange rate

USD

US dollar

1,3857

JPY

Japanese yen

111,87

DKK

Danish krone

7,4562

GBP

Pound sterling

0,86860

SEK

Swedish krona

9,3610

CHF

Swiss franc

1,3708

ISK

Iceland króna

NOK

Norwegian krone

8,1920

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,598

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

271,76

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7097

PLN

Polish zloty

3,9820

RON

Romanian leu

4,2663

TRY

Turkish lira

1,9887

AUD

Australian dollar

1,4216

CAD

Canadian dollar

1,4150

HKD

Hong Kong dollar

10,7467

NZD

New Zealand dollar

1,8280

SGD

Singapore dollar

1,7968

KRW

South Korean won

1 557,90

ZAR

South African rand

9,6827

CNY

Chinese yuan renminbi

9,2437

HRK

Croatian kuna

7,3470

IDR

Indonesian rupiah

12 383,89

MYR

Malaysian ringgit

4,3090

PHP

Philippine peso

59,741

RUB

Russian rouble

42,7523

THB

Thai baht

41,509

BRL

Brazilian real

2,3638

MXN

Mexican peso

17,1544

INR

Indian rupee

61,5200

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
Advisory Board on Radiation and Worker Health

Mound Work Group Meeting Agenda

TELECONFERENCE

Date: May 13, 2010

Conference Call Number: (866)-659-0537

Participant Pass Code: 9933701

Start Time: 10:00 A.M. Eastern Time

1. Ted Katz: Call to order and roll call.

2. Josie Beach: Introduction background and purpose.

3. Brant: NIOSH discussion of proposed SEC class.

4. Joe Fitzgerald: SC&A questions and remaining issues.

5. Work Group: Questions and general discussion. 

6. Further actions and next step.
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




Pursuant
to 18 U.S.C. § 1350, as adopted pursuant to Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that
the Quarterly Report on Form 10-Q for the period ended June 30, 2010 of
Flurida Group, Inc. (the “Company”) fully complies with the requirements of
Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934
and that the information contained in such Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.




Flurida
      Group, Inc.Dated:
      August 10, 2010
              By:
              /s/ Jianfeng DingJianfeng
      DingChief
      Executive Officer





A
signed original of this written statement required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to Flurida Group, Inc. and will
be retained by Flurida Group, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
Exhibit 13.2

|BASF Aktiengesellschaft |  | GRAPHIC
|----------------------- |  | -------

CERTIFICATION  PURSUANT TO 18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO SECTION 906 OF THE  SARBANES-OXLEY ACT

In
connection with the Annual Report on Form 20-F/A of BASF Aktiengesellschaft, a German corporation (the"Company") for the year
ended December 31, 2003 as filed with the Securities and Exchange Commission on March 18, 2004 (the"Report") the undersigned,
Dr. Kurt Bock, Chief Financial Officer of BASF Aktiengesellschaft, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:

|Date: March 18, 2004 |  | By: |  | GRAPHIC
|-------------------- |  | --- |  | -------
|                     |  |     |  |        
|                     |  |     |  | Name:  
|                     |  |     |  | Title: 

---

QuickLinks
**EXHIBIT 4.15.1**

*Ministry of the Russian Federation for Communications*

**Amendment No. 1****to License No. 4879 (registration series A 001498)****dated August 30, 1996**

The name of the entity on the title page shall be change to:

Open Joint Stock Company“Orensot”

Clause 1 of the Conditions For Carrying Out Activities Under License No. 4879 shall be revised to read as follows:

“1.

OJSC “Orensot” (the Licensee) is hereby authorized to provide cellular radio-telephone communications services of the public communication network within the 800 Mhz frequency band on the territory of Orenburg Region.

The cellular communication services shall be provided with the use of the Licensee’s communication network created on the basis of a narrowband AMPS/D-AMPS system.”

 

| **First Deputy Chairman****of the State Committee****on Communications****of the Russian Federation** |   | [Signature]       |   | **N. S. Marder**      |   |
|-------------------------------------------------------------------------------------------------------|--------|-------------------|--------|-----------------------|--------|
|                                                                                                  |   |              |   |  ****            |   |
|                                                                                                  |   |              |   | December 27, 1999**** |   |
|                                                                                                  |   |              |   |  ****            |   |
| **Head of the Department****of the Organization****of Licensing Activity**                            |   | [Signature][Seal] |   | **N. M. Popov**  |   |

 10
AGENDA

Advisory Board on Radiation and Worker Health 

Meeting of the

LANL Work Group

May 2, 2011

Cincinnati Airport Marriott 

2395 Progress Dr. 

Hebron, KY 41048 

859-586-0166

Conference Call Number: 1-866-659-0537

Participant Pass Code: 9933701

9:00 a.m. Welcome and roll-call/introductions 

Work Group Discussion

• ISSUE 1: LANL CAPABILITY TO MONITOR AND MEASURE MIXED FISSION AND 

ACTIVATION PRODUCTS BY 1976 

• ISSUE 2: NIOSH’S ASSUMPTION REGARDING INTAKE VALUES FOR EXOTIC 

RADIONUCLIDES AT LANL 

• ISSUE 3: COMPLETENESS AND RELIABILITY OF LANL IN-VITRO AND IN-VIVO 

DATA, AND ADEQUACY OF NIOSH COWORKER MODEL (ORAUT-OTIB-0062 AND 

ORAUT-OTIB-0063), POST 1975 

• ISSUE 4: FEASIBILITY OF DOSE ESTIMATION FOR NEUTRON EXPOSURE AT LANL, 

POST 1975

• ISSUE 5: FEASIBILITY OF DOSE ESTIMATION FOR RADIOLOGICAL EXPOSURE 

SOURCES AT LAMPF/LANSCE (EXPOSURE TO WORKERS ADJACENT TO THE 

FACILITY)

• ISSUE 6: RADIATION EXPOSURE TO SPECIAL TRITIUM COMPOUNDS

• ISSUE 7: UNMONITORED EXPOSURE OF SUPPORT SERVICE PERSONNEL 

• PETITIONER ISSUES 1-8 

Action Items Summary

Next WG Meeting/Plans

Adjourn
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [FDA No. 225-07-8004]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice.

# SUMMARY:

                        The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and                               ( print page 1620)                            the University of California, Davis campus (UC Davis). The purpose of this MOU is to establish terms of collaboration between FDA and UC Davis, focused primarily but not exclusively, in the areas of the safety and security of foods and cosmetics, animal feeds and veterinary products. Beyond the collaborations in the traditional academic programs for training, research and outreach, this MOU will also include UC Davis extended partnerships such as the Western Institute for Food Safety and Security, and the Center for Produce Safety.                    

# DATES:

The agreement became effective December 7, 2007.

# FOR FURTHER INFORMATION CONTACT:

Mary I. Poos, Office of the Commissioner, Office of the Chief Medical Officer (HF-40), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-2825.

# SUPPLEMENTARY INFORMATION:

                    In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the                     **Federal Register**                    , the agency is publishing notice of this MOU.                

Dated: December 26, 2007.

Jeffrey Shuren,

Assistant Commissioner for Policy.

      ( print page 1621)          ( print page 1622)          ( print page 1623)          ( print page 1624)          ( print page 1625)          ( print page 1626)          ( print page 1627)          ( print page 1628)          ( print page 1629)          ( print page 1630)    

BILLING CODE 4160-01-S

[FR Doc. 08-30 Filed 1-8-08; 8:45 am]

BILLING CODE 4160-01-C
AGENDA

Advisory Board on Radiation and Worker Health – Meeting 85 

Teleconference Meeting

August 15, 2012; 11:00 a.m. Eastern Time 

Teleconference Phone: 866-659-0537 

Participant Code: 9933701 

11:00 a.m. (Eastern Time) Start

• Roll-call – Mr. Katz, DFO

• Welcome – Dr. Melius, Chair

• Recording Absent Member Votes from February Meeting – Mr. Katz, DFO

• Ventron Corporation (Beverly, MA) SEC Petition – Dr. Glover, DCAS; ____ 

Petitioner(s)

• Dose Reconstruction Review Subcommittee Update – Mr. Mark Griffon,

Subcommittee Chair

• Special Exposure Cohort (SEC) Petition Status Update – Mr. Rutherford, DCAS

(On DCAS petition evaluations to be presented at the September 2012 Board meeting) 

• Updates from Work Groups and Subcommittees (as necessary) – WG/SC Chairs

• Board Correspondence – Dr. Melius, Chair

• Plans for the September 2012 Board Meeting Agenda – All Members
EXHIBIT
32.2





CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





The
undersigned hereby certifies, in his capacity as an officer of Rongfu
Aquaculture, Inc. (the "Company"), for the purposes of 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
the best of his or her knowledge:





(1)
            The
      Amendment No. 1 to the Quarterly Report of the Company on Form 10-Q for
      the quarter ended March 31, 2010 fully complies with the requirements
      of Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
      and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.






Dated:
December 29, 2010




/s/ Keith HorKeith
      HorChief
      Financial Officer




A signed
original of this written statement required by Section 906 has been provided to
Rongfu Aquaculture, Inc. and will be retained by Rongfu Aquaculture, Inc. and
furnished to the Securities and Exchange Commission or its staff upon
request.
#### Carl Krob *v.*Glenn Straub’s, Inc.

(No. 14592)

Decided March 11, 1980.

*324*Bailey, By rum & Vieweg and John Preston Bailey*for appellant.

No appearance for appellee.

Per Curiam:

In this proceeding the appellant, Carl Krob, contends that the Circuit Court of Ohio County erred in dismissing his action against Glenn Straub’s, Inc., a corporation, on the ground that there had been defective service of process. It is the appellant’s position that the corporation, by appearing generally before a magistrate, waived all defects in service. We agree with his contention.

On November 14, 1977, the appellant filed suit against the appellee corporation in the Magistrate Court of Ohio County. Two days later, a deputy sheriff served process in the case upon William Lewis, the corporation’s sales manager. Without contesting the service the corporation filed an answer and later appeared generally at the trial of the case. At the conclusion of the trial the magistrate awarded the appellant judgment. The corporation appealed the magistrate’s decision to the Circuit Court of Ohio County and moved for a dismissal on the ground that there had been insufficient service of process. The court conducted a hearing on the motion to dismiss and, on March 6, 1977, granted the motion and entered the order from which the appellant now appeals.

In *Layne v. Ohio River Company,*35 W.Va. 438, 14 S.E. 123 (1891), we held that to take advantage of a defect in the summons or return in a case it was necessary for a defendant to appear specially for the purpose of challenging the summons or return. We concluded that if he appeared generally, whether to move for a continuance or for any other purpose, he would be regarded as hav*325ing waived all defects in the writ or the return. In Syllabus Point 4 of the same case, we said:

> “A defendant who has waived all objections to the summons and return in the justice’s court, by appearing there and submitting to a trial, cannot, on appeal to the circuit court, take advantage of any defect in the writ or return, either by motion to quash or by a plea in abatement.”

Cf. *Kester v. Kester,*106 W.Va. 615, 146 S.E. 625 (1929), and *Blankenship v. Kanawha & M. Ry. Co.,*43 W.Va. 135, 27 S.E. 355 (1897).

The legal questions presented in the case before us are identical to those raised in *Layne, supra.*Although *Layne*was decided before conversion of our justice of the peace system into the magistrate system, the operative legal principle enunciated in Syllabus Point 4 of *Layne*has not been altered. In accordance with the holding of that syllabus point we conclude that Glenn Straub’s, Inc., by appearing generally in the magistrate court, waived all defects in service of process and could not properly on appeal to the circuit court have taken advantage of those defects. The circuit court, in permitting the corporation to take advantage of those defects, and in granting the motion to dismiss, erred.

Therefore, the judgment of the Circuit Court of Ohio County is reversed; the order dismissing the case is set aside; and the case is remanded for further development.

*Reversed and remanded.*
# Continuation of the National Emergency With Respect to the Former Liberian Regime of Charles Taylor

On July 22, 2004, by Executive Order 13348, I declared a national emergency and ordered related measures, including the blocking of the property of certain persons connected to the former Liberian regime of Charles Taylor, pursuant to the International Emergency Economic Powers Act (50 U.S.C. 1701-1706). I took this action to deal with the unusual and extraordinary threat to the foreign policy of the United States constituted by the actions and policies of former Liberian President Charles Taylor and other persons, in particular their unlawful depletion of Liberian resources and their removal from Liberia and secreting of Liberian funds and property, which have undermined Liberia's transition to democracy and the orderly development of its political, administrative, and economic institutions and resources. I further noted that the Comprehensive Peace Agreement signed on August 18, 2003, and the related cease-fire had not yet been universally implemented throughout Liberia, and that the illicit trade in round logs and timber products was linked to the proliferation of and trafficking in illegal arms, which perpetuated the Liberian conflict and fueled and exacerbated other conflicts throughout West Africa.

The actions and policies of Charles Taylor and others have left a legacy of destruction that continues to undermine Liberia's transformation and recovery. Because the actions and policies of these persons continue to pose an unusual and extraordinary threat to the foreign policy of the United States, the national emergency declared on July 22, 2004, and the measures adopted on that date to deal with that emergency, must continue in effect beyond July 22, 2008. Therefore, in accordance with section 202(d) of the National Emergencies Act (50 U.S.C. 1622(d)), I am continuing for 1 year the national emergency declared in Executive Order 13348.

                        This notice shall be published in the                         **Federal Register**                         and transmitted to the Congress.                    

[FR Doc. 08-1452

Billing code 3195-W8-P
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Equal Employment Opportunity Commission

      ( print page 28114)    

# Agency Holding the Meeting:

Equal Employment Opportunity Commission. 

# Federal Register Citation of Previous Announcement:

73 FR 26395, Friday, May 9, 2008. 

# Previously Announced Time and Date of Meeting:

Tuesday, May 13, 2008, 10 a.m. (Eastern Time). 

# Change in the Meeting:

The meeting has been cancelled. 

# Contact Person for More Information:

Stephen Llewellyn, Executive Officer on (202) 663-4070. 

Dated: May 12, 2008. 

Stephen Llewellyn, 

Executive Officer, Executive Secretariat.

[FR Doc. 08-1268 Filed 5-13-08; 1:35 pm] 

BILLING CODE 6570-01-P
|         1.  The      Report is in full compliance with reporting requirements of Section 13(a)      of the Securities Exchange Act of 1934, as amended;  and |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|         2.      The information contained in the Report fairly presents, in all material      respects, the financial condition and results of operation of the      Corporation. |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Global      Holdings, Inc.                                                                           |
|--------|------------------------------------------------------------------------------------------------------|
|   |                                                                                                 |
|   | /s/      Mitchell Cohen                                                                              |
|   | Mitchell      Cohen                                                                                  |
|   | CEO,      CFO, Principal Accounting Officer, President, Chairman      of the Board ofDirectors  |
Exhibit 10.17

                     FIRST AMENDMENT TO
                 ENRON CORP. 1991 STOCK PLAN
       (AS AMENDED AND RESTATED EFFECTIVE MAY 4, 1999)


WHEREAS, ENRON CORP. (the "Company") and the stockholders of
the Company have heretofore approved and adopted the Enron
Corp. 1991 Stock Plan (As Amended and Restated Effective May
4, 1999)(the "Plan"); and

WHEREAS, the Company desires to amend the Plan.

NOW, THEREFORE, the Plan is amended as follows:

New paragraph C is added under Section 6.2:

       "C.  A nonemployee Director who is not a resident of
  the United States of America, who is required by the
  Company to defer a portion of his Retainer Fee into the
  Enron Corp. 1994 Deferral Plan, and whose deferral is
  regarded as the receipt of taxable income under the tax
  laws of the country in which the director resides or has
  citizenship, upon notification thereof to the Committee,
  in a form acceptable to the Committee, may elect to waive
  that portion of his Retainer Fee that is required to be
  so deferred and in lieu thereof receive an award of
  Phantom Stock Units under the Plan.  Upon the Committee's
  receipt and approval of such election, at its next
  regularly scheduled meeting the Committee shall approve
  an award of Phantom Stock Units to such nonemployee
  Director in a number determined by the Committee that
  will reflect the value of such portion of the Retainer
  Fee that is waived by the non-employee Director for the
  calendar year.  Thereafter, as long as such non-employee
  Director does not revoke his election, as of July 1 of
  each year, the Committee shall approve an award of
  Phantom Stock Units to such nonemployee Director in a
  number determined by the Committee that will reflect the
  value of such portion of the Retainer Fee that is waived
  by the non-employee Director for the calendar year.  Such
  award of Phantom Stock Units will fully vest on the fifth
  anniversary of the date of grant."

AS AMENDED HEREBY, the Plan is specifically ratified and
reaffirmed.

Date:  August 11, 1999                  ENRON CORP.

                                    By: /s/ MARY K. JOYCE
                                   Mary K. Joyce
                                   Vice-President,
                                   Compensation & Benefits

ATTEST:


By: /s/ REBECCA C. CARTER
Title: